Summary

Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.

The global Respiratory Distress Syndrome market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for Respiratory Distress Syndrome are the significant development of demand and improvement of COVID-19 and geo-economics.

Based on the type of product, the global Respiratory Distress Syndrome market segmented into
Poractant Alfa
Beractant
Calfactant
Others

Based on the end-use, the global Respiratory Distress Syndrome market classified into
Very Preterm Infants
Moderate to Late Preterm Infants
Others

Based on geography, the global Respiratory Distress Syndrome market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

And the major players included in the report are
Chiesi Farmaceutici
CR-Double Crane
ONY Biotech
AbbVie
Yuhan Corporation
JW Pharmaceuticals
Noargen
Market Breakdown by Regions
North America
Europe
China
Korea
RoW

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL RESPIRATORY DISTRESS SYNDROME INDUSTRY
2.1 Summary about Respiratory Distress Syndrome Industry
2.2 Respiratory Distress Syndrome Market Trends
2.2.1 Respiratory Distress Syndrome Production & Consumption Trends
2.2.2 Respiratory Distress Syndrome Demand Structure Trends
2.3 Respiratory Distress Syndrome Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Poractant Alfa
4.2.2 Beractant
4.2.3 Calfactant
4.2.4 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Very Preterm Infants
4.3.2 Moderate to Late Preterm Infants
4.3.3 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Poractant Alfa
5.2.2 Beractant
5.2.3 Calfactant
5.2.4 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Very Preterm Infants
5.3.2 Moderate to Late Preterm Infants
5.3.3 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Poractant Alfa
6.2.2 Beractant
6.2.3 Calfactant
6.2.4 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Very Preterm Infants
6.3.2 Moderate to Late Preterm Infants
6.3.3 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Poractant Alfa
7.2.2 Beractant
7.2.3 Calfactant
7.2.4 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Very Preterm Infants
7.3.2 Moderate to Late Preterm Infants
7.3.3 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Poractant Alfa
8.2.2 Beractant
8.2.3 Calfactant
8.2.4 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Very Preterm Infants
8.3.2 Moderate to Late Preterm Infants
8.3.3 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Poractant Alfa
9.2.2 Beractant
9.2.3 Calfactant
9.2.4 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Very Preterm Infants
9.3.2 Moderate to Late Preterm Infants
9.3.3 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Chiesi Farmaceutici
10.1.2 CR-Double Crane
10.1.3 ONY Biotech
10.1.4 AbbVie
10.1.5 Yuhan Corporation
10.1.6 JW Pharmaceuticals
10.1.7 Noargen
10.1.8 Market Breakdown by Regions
10.1.9 North America
10.1.10 Europe
10.1.11 China
10.1.12 Korea
10.1.13 RoW
10.2 Respiratory Distress Syndrome Sales Date of Major Players (2017-2020e)
10.2.1 Chiesi Farmaceutici
10.2.2 CR-Double Crane
10.2.3 ONY Biotech
10.2.4 AbbVie
10.2.5 Yuhan Corporation
10.2.6 JW Pharmaceuticals
10.2.7 Noargen
10.2.8 Market Breakdown by Regions
10.2.9 North America
10.2.10 Europe
10.2.11 China
10.2.12 Korea
10.2.13 RoW
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT


List of Table
1.Table Respiratory Distress Syndrome Product Type Overview
2.Table Respiratory Distress Syndrome Product Type Market Share List
3.Table Respiratory Distress Syndrome Product Type of Major Players
4.Table Brief Introduction of Chiesi Farmaceutici
5.Table Brief Introduction of CR-Double Crane
6.Table Brief Introduction of ONY Biotech
7.Table Brief Introduction of AbbVie
8.Table Brief Introduction of Yuhan Corporation
9.Table Brief Introduction of JW Pharmaceuticals
10.Table Brief Introduction of Noargen
11.Table Brief Introduction of Market Breakdown by Regions
12.Table Brief Introduction of North America
13.Table Brief Introduction of Europe
14.Table Brief Introduction of China
15.Table Brief Introduction of Korea
16.Table Brief Introduction of RoW
17.Table Products & Services of Chiesi Farmaceutici
18.Table Products & Services of CR-Double Crane
19.Table Products & Services of ONY Biotech
20.Table Products & Services of AbbVie
21.Table Products & Services of Yuhan Corporation
22.Table Products & Services of JW Pharmaceuticals
23.Table Products & Services of Noargen
24.Table Products & Services of Market Breakdown by Regions
25.Table Products & Services of North America
26.Table Products & Services of Europe
27.Table Products & Services of China
28.Table Products & Services of Korea
29.Table Products & Services of RoW
30.Table Market Distribution of Major Players
31.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
32.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
33.Table Global Respiratory Distress Syndrome Market Forecast (Million USD) by Region 2021f-2026f
34.Table Global Respiratory Distress Syndrome Market Forecast (Million USD) Share by Region 2021f-2026f
35.Table Global Respiratory Distress Syndrome Market Forecast (Million USD) by Demand 2021f-2026f
36.Table Global Respiratory Distress Syndrome Market Forecast (Million USD) Share by Demand 2021f-2026f

List of Figure
1.Figure Global Respiratory Distress Syndrome Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Respiratory Distress Syndrome Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Respiratory Distress Syndrome Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Respiratory Distress Syndrome Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Respiratory Distress Syndrome Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Respiratory Distress Syndrome Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Respiratory Distress Syndrome Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Poractant Alfa Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Beractant Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Calfactant Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Very Preterm Infants Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Moderate to Late Preterm Infants Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Poractant Alfa Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Beractant Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Calfactant Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure Very Preterm Infants Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure Moderate to Late Preterm Infants Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Poractant Alfa Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure Beractant Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure Calfactant Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure Very Preterm Infants Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure Moderate to Late Preterm Infants Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Poractant Alfa Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Beractant Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure Calfactant Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Very Preterm Infants Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Moderate to Late Preterm Infants Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Poractant Alfa Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Beractant Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure Calfactant Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure Very Preterm Infants Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Moderate to Late Preterm Infants Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
66.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
67.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
68.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
69.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
70.Figure Poractant Alfa Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
71.Figure Beractant Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
72.Figure Calfactant Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
73.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
74.Figure Very Preter

Global Cephalosporin Drug Market (2024 Edition): Analysis by Generation (First, Second, Third, Fourth, Fifth), Route of Administration, Application (Respiratory Tract Infection, Skin Infection, Urinary Tract Infection, Others), By Region, By Country: Market Insights and Forecast (2019-2029)...

Executive Summary Azoth Analytics has released a research report titled "Global Cephalosporin Drug Market (2024 Edition)" which provides a complete analysis of the Global Cephalosporin Drug industry in terms of market segmentation By Generation (First Generation, Second Generation, Thir...

Global Respiratory Diagnostics Market Report- Global Strategic Analysis, Size, Share, Trend, and Forecast (2023-2030)...

This report gives an insight into the global Respiratory Diagnostics Market and predicts the future growth prospects and the trends that may exhibit in the market during the period of 2023-2030. The future growth has been calculated by taking into account the present growth rate and the overall mark...

Global Polycystic Ovary Syndrome (PCOS) Blood Test Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Polycystic Ovary Syndrome (PCOS) Blood Test Market: The report discusses everything a marketer requires before investing in the global Polycystic Ovary Syndrome (PCOS) Blood Test Market during...

Global Machine Learning in Respiratory Diseases Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Machine Learning in Respiratory Diseases Market: The report discusses everything a marketer requires before investing in the global Machine Learning in Respiratory Diseases Market during the f...

Asia Pacific Medical Device Market 2022-2032 by Category (Diagnostic, Consumables, Patient Aids, Orthopaedics, Dental, Others), Application (Imaging, IVDs, Cardiology, Orthopedics, Ophthalmics, Respiratory), End User (Hospitals, Clinics, Household), and Country: Trend Forecast and Growth Opportunity...

Asia Pacific medical device market will grow by 8.4% annually with a total addressable market cap of $2.06 trillion over 2023-2032, driven by the prevalence of infectious diseases as well as the increasing prevalence of chronic diseases, technological innovation, and penetration of healthcare insura...

Europe Medical Device Market 2022-2032 by Category (Diagnostic, Consumables, Patient Aids, Orthopaedics, Dental, Others), Application (Imaging, IVDs, Cardiology, Orthopedics, Ophthalmics, Respiratory), End User (Hospitals, Clinics, Household), and Country: Trend Forecast and Growth Opportunity...

Europe medical device market was valued at $144.4 billion in 2022 and will grow by 4.7% annually over 2022-2032, driven by the prevalence of infectious diseases as well as the increasing prevalence of chronic diseases, technological innovation, and penetration of healthcare insurance. Highlig...

North America Medical Device Market 2022-2032 by Category (Diagnostic, Consumables, Patient Aids, Orthopaedics, Dental, Others), Application (Imaging, IVDs, Cardiology, Orthopedics, Ophthalmics, Respiratory), End User (Hospitals, Clinics, Household), and Country: Trend Forecast and Growth Opportunity...

North America medical device market is projected to grow by 3.9% annually in the forecast period and reach $ 282.3 billion by 2032, driven by the prevalence of infectious diseases as well as the increasing prevalence of chronic diseases, technological innovation, and penetration of healthcare insura...

Global Medical Device Market 2022-2032 by Category (Diagnostic, Consumables, Patient Aids, Orthopaedics, Dental, Others), Application (Imaging, IVDs, Cardiology, Orthopedics, Ophthalmics, Respiratory), End User (Hospitals, Clinics, Household), and Region: Trend Forecast and Growth Opportunity...

Global medical device market will reach $882.3 billion by 2032, growing by 5.5% annually over 2022-2032 owing to aging population worldwide, the prevalence of infectious diseases as well as the increasing prevalence of chronic diseases, technological innovation, and penetration of healthcare insuran...

Global Respiratory Health Solutions Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Respiratory Health Solutions Market: The report discusses everything a marketer requires before investing in the global Respiratory Health Solutions Market during the forecast period 2023-2030...

2023-2028 Global and Regional Respiratory Panel Assays Industry Status and Prospects Professional Market Research Report Standard Version...

The global Respiratory Panel Assays market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in ...